Scotts Miracle-Gro's Q4 Earnings and Revenues Miss Estimates

07.11.25 17:14 Uhr

Werte in diesem Artikel
Aktien

49,62 EUR 0,80 EUR 1,64%

Indizes

1.854,4 PKT -8,4 PKT -0,45%

The Scotts Miracle-Gro Company SMG reported a fourth-quarter fiscal 2025 (ended Sept. 30, 2025) loss of $151.8 million or $2.63 per share compared with a loss of $244 million or $4.29 per share in the year-ago quarter.Barring one-time items, adjusted loss was $1.96 per share, narrower than $2.31 a year ago. The figure was wider than the Zacks Consensus Estimate of a loss of $1.88.Net sales decreased around 6.6% year over year to $387.4 million and missed the consensus mark of $398.6 million.The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise The Scotts Miracle-Gro Company price-consensus-eps-surprise-chart | The Scotts Miracle-Gro Company QuoteSMG’s Segment DetailsIn the fiscal fourth quarter, net sales in the U.S. Consumer division were up 0.5% year over year to $311.2 million. It missed our estimate of $360 million. The segment delivered a loss of $65.5 million, up 21% year over year.Net sales in the Hawthorne segment tumbled 38% year over year to $49.9 million in the reported quarter. The figure beat our estimate of $27 million. Net sales in the other segment increased 7% year over year to $26.3 million. The figure topped our estimate of $5.3 million. The segment reported a loss of $9.8 million, down 20% year over year.SMG’s Balance SheetAt the end of the quarter, the company had cash and cash equivalents of $36.6 million, down from $71.6 million a year ago. Long-term debt was $2,049.2 million, down around 5.7% year over year.SMG’s OutlookThe company provided its full-year fiscal 2026 outlook. Key projections include low single-digit growth in U.S. Consumer net sales. The adjusted gross margin is expected to be at least 32%, with adjusted EBITDA anticipated to grow in the mid-single digits. Adjusted earnings per share are projected to be between $4.15-$4.35, and free cash flow is estimated at approximately $275 million.SMG’s Price PerformanceShares of Scotts Miracle-Gro have lost 19% in the past year compared the 5.4% decline of the industry.Image Source: Zacks Investment ResearchSMG’s Zacks Rank & Other Key PicksSMG currently carries a Zacks Rank #2 (Buy).Some other top-ranked stocks worth a look in the basic materials space are AngloGold Ashanti plc AU, U.S. Gold Corp. USAU and Integra Resources Corp. ITRG.AngloGold is scheduled to report third-quarter results on Nov. 11. The Zacks Consensus Estimate for AU’s third-quarter earnings and revenues is pegged at $1.34 per share and $2.35 billion, respectively. AU currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.U.S. Goldis expected to report fiscal second-quarter results on Dec. 15. USAU carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for USAU’s second-quarter earnings is pegged at a loss of 13 cents, indicating a 35% year-over-year growth.Integra Resources is scheduled to report third-quarter results on Nov. 12. ITRG’s earnings estimate for the third quarter is pegged at 13 cents per share. Integra Resources carries a Zacks Rank #2 at present.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AngloGold Ashanti PLC (AU): Free Stock Analysis Report The Scotts Miracle-Gro Company (SMG): Free Stock Analysis Report US Gold Corp (USAU): Free Stock Analysis Report Integra Resources Corp. (ITRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: The Scotts Miracle-Gro Company und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu The Scotts Miracle-Gro Company

Wer­bung

Analysen zu The Scotts Miracle-Gro Company

DatumRatingAnalyst
11.01.2017The Scotts Miracle-Gro Company HoldSunTrust
20.10.2016The Scotts Miracle-Gro Company BuyGabelli & Co
22.12.2006Update The Scotts Miracle-Gro Company: NeutralPrudential Securities
17.08.2005Update The Scotts Miracle-Gro Company: BuySun Trust Robinson Humphrey
28.07.2005Update The Scotts Miracle-Gro Company: OverweightJP Morgan
DatumRatingAnalyst
20.10.2016The Scotts Miracle-Gro Company BuyGabelli & Co
17.08.2005Update The Scotts Miracle-Gro Company: BuySun Trust Robinson Humphrey
28.07.2005Update The Scotts Miracle-Gro Company: OverweightJP Morgan
28.07.2005Update The Scotts Miracle-Gro Company: Market OutpAvondale Partners
29.06.2005Update The Scotts Miracle-Gro Company: BuyKeyBanc Capital Markets / McDonald
DatumRatingAnalyst
11.01.2017The Scotts Miracle-Gro Company HoldSunTrust
22.12.2006Update The Scotts Miracle-Gro Company: NeutralPrudential Securities
04.01.2005Update Scotts Co.: NeutralJP Morgan
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Scotts Miracle-Gro Company nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen